Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results
Summary
CNBC's Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly ...
CNBC's Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly earnings results, late-stage trial data on its experimental obesity pill orforglipron, drug pipeline outlook, and more.
Tags
LLY